Pretreatment Markers of Systemic Inflammation and Outcomes With Stereotactic Radiosurgery for Brain Metastases

MLA

Percy Lee, et al. “Pretreatment Markers of Systemic Inflammation and Outcomes With Stereotactic Radiosurgery for Brain Metastases.” International Journal of Radiation Oncology*Biology*Physics, vol. 96, Oct. 2016, p. E73. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2016.06.774.

APA

Percy Lee, Rebecca Levin-Epstein, Narek Shaverdian, Jason Wang, Dörthe Schaue, Tania Kaprealian, & P.A. Kupelian. (2016). Pretreatment Markers of Systemic Inflammation and Outcomes With Stereotactic Radiosurgery for Brain Metastases. International Journal of Radiation Oncology*Biology*Physics, 96, E73. https://doi.org/10.1016/j.ijrobp.2016.06.774

Chicago

Percy Lee, Rebecca Levin-Epstein, Narek Shaverdian, Jason Wang, Dörthe Schaue, Tania Kaprealian, and P.A. Kupelian. 2016. “Pretreatment Markers of Systemic Inflammation and Outcomes With Stereotactic Radiosurgery for Brain Metastases.” International Journal of Radiation Oncology*Biology*Physics 96 (October): E73. doi:10.1016/j.ijrobp.2016.06.774.